{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:21:44Z","timestamp":1760242904177,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00432-017-2528-x","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T08:24:13Z","timestamp":1507710253000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck"],"prefix":"10.1007","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-856X","authenticated-orcid":false,"given":"Till Sebastian","family":"Clauditz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Hanken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Borgmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Wilczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Grob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"M\u00fcnscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"2528_CR1","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1158\/1078-0432.CCR-13-0190","volume":"19","author":"F Andre","year":"2013","unstructured":"Andre F, Bachelot T, Campone M, Dalenc F, Perez-Garcia JM, Hurvitz SA, Turner N, Rugo H, Smith JW, Deudon S, Shi M, Zhang Y, Kay A, Porta DG, Yovine A, Baselga J (2013) Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer. Clin Cancer Res 19:3693\u20133702. doi:\n                        10.1158\/1078-0432.CCR-13-0190","journal-title":"Clin Cancer Res"},{"key":"2528_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567\u2013578. doi:\n                        10.1056\/NEJMoa053422","journal-title":"N Engl J Med"},{"key":"2528_CR3","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/bjc.2011.440","volume":"105","author":"G Bousquet","year":"2011","unstructured":"Bousquet G, Alexandre J, Le Tourneau C, Goldwasser F, Faivre S, de Mont-Serrat H, Kaiser R, Misset JL, Raymond E (2011) Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients. Br J Cancer 105:1640\u20131645. doi:\n                        10.1038\/bjc.2011.440","journal-title":"Br J Cancer"},{"key":"2528_CR4","doi-asserted-by":"publisher","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","volume":"23","author":"B Burtness","year":"2005","unstructured":"Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA (2005) Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic\/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 23:8646\u20138654. doi:\n                        10.1200\/JCO.2005.02.4646","journal-title":"J Clin Oncol"},{"key":"2528_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ijc.11627","volume":"108","author":"X Castellsague","year":"2004","unstructured":"Castellsague X, Quintana MJ, Martinez MC, Nieto A, Sanchez MJ, Juan A, Monner A, Carrera M, Agudo A, Quer M, Munoz N, Herrero R, Franceschi S, Bosch FX (2004) The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 108:741\u2013749. doi:\n                        10.1002\/ijc.11627","journal-title":"Int J Cancer"},{"key":"2528_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/1933719111432874","volume":"19","author":"YM Cheng","year":"2012","unstructured":"Cheng YM, Chou CY, Hsu YC, Chen MJ (2012) Influence of HPV16 E6\/7 on the expression of FGF2 and FGFR type B in cervical carcinogenesis. Reprod Sci 19:580\u2013586. doi:\n                        10.1177\/1933719111432874","journal-title":"Reprod Sci"},{"key":"2528_CR7","doi-asserted-by":"publisher","first-page":"e20351","DOI":"10.1371\/journal.pone.0020351","volume":"6","author":"A Dutt","year":"2011","unstructured":"Dutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, Chande A, Tanaka KE, Stransky N, Greulich H, Gray NS, Meyerson M (2011) Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS One 6:e20351. doi:\n                        10.1371\/journal.pone.0020351","journal-title":"PLoS One"},{"key":"2528_CR8","first-page":"5271","volume":"9","author":"J Edwards","year":"2003","unstructured":"Edwards J, Krishna NS, Witton CJ, Bartlett JM (2003) Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin Cancer Res 9:5271\u20135281","journal-title":"Clin Cancer Res"},{"key":"2528_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261\u2013269. doi:\n                        10.1093\/jnci\/djn011","journal-title":"J Natl Cancer Inst"},{"key":"2528_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.oraloncology.2006.01.005","volume":"43","author":"K Freier","year":"2007","unstructured":"Freier K, Schwaenen C, Sticht C, Flechtenmacher C, Muhling J, Hofele C, Radlwimmer B, Lichter P, Joos S (2007) Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Oral Oncol 43:60\u201366. doi:\n                        10.1016\/j.oraloncology.2006.01.005","journal-title":"Oral Oncol"},{"key":"2528_CR11","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0140-6736(04)16194-1","volume":"363","author":"ML Gillison","year":"2004","unstructured":"Gillison ML, Lowy DR (2004) A causal role for human papillomavirus in head and neck cancer. Lancet 363:1488\u20131489. doi:\n                        10.1016\/S0140-6736(04)16194-1","journal-title":"Lancet"},{"key":"2528_CR12","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1158\/1078-0432.CCR-07-0502","volume":"13","author":"KL Gorringe","year":"2007","unstructured":"Gorringe KL, Jacobs S, Thompson ER, Sridhar A, Qiu W, Choong DY, Campbell IG (2007) High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clin Cancer Res 13:4731\u20134739. doi:\n                        10.1158\/1078-0432.CCR-07-0502","journal-title":"Clin Cancer Res"},{"key":"2528_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1158\/1535-7163.MCT-11-0450","volume":"11","author":"JM Gozgit","year":"2012","unstructured":"Gozgit JM, Wong MJ, Moran L, Wardwell S, Mohemmad QK, Narasimhan NI, Shakespeare WC, Wang F, Clackson T, Rivera VM (2012) Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. Mol Cancer Ther 11:690\u2013699. doi:\n                        10.1158\/1535-7163.MCT-11-0450","journal-title":"Mol Cancer Ther"},{"key":"2528_CR14","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jnci\/djg107","volume":"95","author":"R Herrero","year":"2003","unstructured":"Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Munoz N, Franceschi S (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95:1772\u20131783","journal-title":"J Natl Cancer Inst"},{"key":"2528_CR15","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","volume":"68","author":"F Hilberg","year":"2008","unstructured":"Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ (2008) BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res 68:4774\u20134782. doi:\n                        10.1158\/0008-5472.CAN-07-6307","journal-title":"Cancer Res"},{"key":"2528_CR16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0006-291X(02)00836-7","volume":"296","author":"T Ishizuka","year":"2002","unstructured":"Ishizuka T, Tanabe C, Sakamoto H, Aoyagi K, Maekawa M, Matsukura N, Tokunaga A, Tajiri T, Yoshida T, Terada M, Sasaki H (2002) Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun 296:152\u2013155","journal-title":"Biochem Biophys Res Commun"},{"key":"2528_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics. CA Cancer J Clin 59:225\u2013249. doi:\n                        10.3322\/caac.20006","journal-title":"CA Cancer J Clin"},{"key":"2528_CR18","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137\u20132150. doi:\n                        10.1200\/JCO.2005.05.2308","journal-title":"J Clin Oncol"},{"key":"2528_CR19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"R Klaes","year":"2001","unstructured":"Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276\u2013284","journal-title":"Int J Cancer"},{"key":"2528_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00428-012-1250-y","volume":"461","author":"LH Kohler","year":"2012","unstructured":"Kohler LH, Mireskandari M, Knosel T, Altendorf-Hofmann A, Kunze A, Schmidt A, Presselt N, Chen Y, Petersen I (2012) FGFR1 expression and gene copy numbers in human lung cancer. Virchows Arch 461:49\u201357. doi:\n                        10.1007\/s00428-012-1250-y","journal-title":"Virchows Arch"},{"key":"2528_CR21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844\u2013847","journal-title":"Nat Med"},{"key":"2528_CR22","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1200\/JCO.2010.33.5208","volume":"29","author":"JA Ledermann","year":"2011","unstructured":"Ledermann JA, Hackshaw A, Kaye S, Jayson G, Gabra H, McNeish I, Earl H, Perren T, Gore M, Persic M, Adams M, James L, Temple G, Merger M, Rustin G (2011) Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer. J Clin Oncol 29:3798\u20133804. doi:\n                        10.1200\/JCO.2010.33.5208","journal-title":"J Clin Oncol"},{"key":"2528_CR23","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1002\/cncr.30135","volume":"122","author":"SH Lim","year":"2016","unstructured":"Lim SH, Sun JM, Choi YL, Kim HR, Ahn S, Lee JY, Lee SH, Ahn JS, Park K, Kim JH, Cho BC, Ahn MJ (2016) Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: a single-arm, phase 2 study. Cancer 122:3024\u20133031. doi:\n                        10.1002\/cncr.30135","journal-title":"Cancer"},{"key":"2528_CR24","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s10552-010-9641-3","volume":"21","author":"TV Macfarlane","year":"2010","unstructured":"Macfarlane TV, Macfarlane GJ, Oliver RJ, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H, Lagiou P, Lagiou A, Castellsague X, Agudo A, Merletti F, Richiardi L, Kjaerheim K, Slamova A, Schejbalova M, Canova C, Simonato L, Talamini R, Barzan L, Conway DI, McKinney PA, Znaor A, Lowry RJ, Thomson P, Healy CM, McCartan BE, Marron M, Hashibe M, Brennan P (2010) The aetiology of upper aerodigestive tract cancers among young adults in Europe: the ARCAGE study. Cancer Causes Control 21:2213\u20132221. doi:\n                        10.1007\/s10552-010-9641-3","journal-title":"Cancer Causes Control"},{"key":"2528_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/era.12.91","volume":"12","author":"A Markovic","year":"2012","unstructured":"Markovic A, Chung CH (2012) Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 12:1149\u20131159. doi:\n                        10.1586\/era.12.91","journal-title":"Expert Rev Anticancer Ther"},{"key":"2528_CR26","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/1078-0432.CCR-11-0050","volume":"17","author":"ME Marshall","year":"2011","unstructured":"Marshall ME, Hinz TK, Kono SA, Singleton KR, Bichon B, Ware KE, Marek L, Frederick BA, Raben D, Heasley LE (2011) Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells. Clin Cancer Res 17:5016\u20135025. doi:\n                        10.1158\/1078-0432.CCR-11-0050","journal-title":"Clin Cancer Res"},{"key":"2528_CR27","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.1158\/1078-0432.CCR-06-1164","volume":"12","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C, Mackay A, Grigoriadis A, Sarrio D, Savage K, Dexter T, Iravani M, Fenwick K, Weber B, Hardisson D, Schmitt FC, Palacios J, Lakhani SR, Ashworth A (2006) FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res 12:6652\u20136662. doi:\n                        10.1158\/1078-0432.CCR-06-1164","journal-title":"Clin Cancer Res"},{"key":"2528_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23443","author":"A Schrock","year":"2013","unstructured":"Schrock A, Goke F, Wagner P, Bode M, Franzen A, Huss S, Agaimy A, Ihrler S, Kirsten R, Kristiansen G, Bootz F, Lengerke C, Perner S (2013) Fibroblast-growth-factor-receptor-1 as a potential therapeutic target in sinonasal cancer? Head Neck. doi:\n                        10.1002\/hed.23443","journal-title":"Head Neck"},{"key":"2528_CR29","first-page":"4514","volume":"61","author":"R Simon","year":"2001","unstructured":"Simon R, Richter J, Wagner U, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G (2001) High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res 61:4514\u20134519","journal-title":"Cancer Res"},{"key":"2528_CR30","volume-title":"TNM classification of malignant tumors","author":"LH Sobin","year":"2009","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors. Wiley-Blackwell, New York"},{"key":"2528_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2012.06.011","author":"L Sweeny","year":"2012","unstructured":"Sweeny L, Zimmermann TM, Liu Z, Rosenthal EL (2012) Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts. Oral Oncol. doi:\n                        10.1016\/j.oraloncology.2012.06.011","journal-title":"Oral Oncol"},{"key":"2528_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nrc2780","volume":"10","author":"N Turner","year":"2010","unstructured":"Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10:116\u2013129. doi:\n                        10.1038\/nrc2780","journal-title":"Nat Rev Cancer"},{"key":"2528_CR33","doi-asserted-by":"publisher","first-page":"62ra93","DOI":"10.1126\/scitranslmed.3001451","volume":"2","author":"J Weiss","year":"2010","unstructured":"Weiss J, Sos ML, Seidel D, Peifer M, Zander T, Heuckmann JM, Ullrich RT, Menon R, Maier S, Soltermann A, Moch H, Wagener P, Fischer F, Heynck S, Koker M, Schottle J, Leenders F, Gabler F, Dabow I, Querings S, Heukamp LC, Balke-Want H, Ansen S, Rauh D, Baessmann I, Altmuller J, Wainer Z, Conron M, Wright G, Russell P, Solomon B, Brambilla E, Brambilla C, Lorimier P, Sollberg S, Brustugun OT, Engel-Riedel W, Ludwig C, Petersen I, Sanger J, Clement J, Groen H, Timens W, Sietsma H, Thunnissen E, Smit E, Heideman D, Cappuzzo F, Ligorio C, Damiani S, Hallek M, Beroukhim R, Pao W, Klebl B, Baumann M, Buettner R, Ernestus K, Stoelben E, Wolf J, Nurnberg P, Perner S, Thomas RK (2010) Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2:62ra93. doi:\n                        10.1126\/scitranslmed.3001451","journal-title":"Sci Transl Med"},{"key":"2528_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.01.006","author":"RJ Young","year":"2013","unstructured":"Young RJ, Lim AM, Angel C, Collins M, Deb S, Corry J, Wiesenfeld D, Kleid S, Sigston E, Lyons B, Russell PA, Wright G, McArthur GA, Fox SB, Rischin D, Solomon B (2013) Frequency of Fibroblast Growth Factor Receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome. Oral Oncol. doi:\n                        10.1016\/j.oraloncology.2013.01.006","journal-title":"Oral Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-017-2528-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T03:25:20Z","timestamp":1515209120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-017-2528-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2528"],"URL":"https:\/\/doi.org\/10.1007\/s00432-017-2528-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2017,10,11]]}}}